Featured Posts
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Search Posts
Newsletter
Global Warming Apathy, Pelosi on Oil Drilling and Government Health Care
A new survey suggests that public concern about global warming is on the decline. House Speaker Nancy Pelosi reverses her opposition to a vote on…
Study
FDA’s Bad Medicine
How the dispersed knowledge problem affects drug safety analysis and how markets and technology will help patients…
Newsletter
Losses at Fannie Mae, Satellite TV Merger and Toxic Chemicals
Mortgage giant Fannie Mae reports a loss of $2.3 billion. Cable TV provider Dish Network proposes a merger with DirecTV. Former New York Times environmental…
Newsletter
Global Warming Allergies, Change at the SEC and Accounting for the Cost of Government
Global warming gets blamed for an increase in allergies. Paul Atkins steps down as Commissioner of the U.S. Securities and Exchange Commission. Taxpayer advocates observe…
Newsletter
Costs of Regulation, FDA Reform and Global Warming Skepticism
The House Small Business Committee hears testimony on the costs of federal regulation. Patient advocates urge lawmakers to pass legislation forcing the Food and Drug…
Citation